The global respiratory inhalers market size was valued at USD 35.31 Billion in 2025, with Asia Pacific holding a significant market share. It is expected to grow at a CAGR of 5.40% during the forecast period of 2026-2035, with the values likely to attain USD 59.75 Billion by 2035. The market growth is driven by increasing cases of respiratory disorders and growing adoption of smart inhalers across the region. Expanding healthcare infrastructure, rising awareness of chronic respiratory diseases, and technological advancements in inhaler devices are anticipated to fuel market growth. Furthermore, supportive government initiatives and increased access to affordable treatments are expected to enhance market value during the forecast period.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
5.4%
Value in USD Billion
2026-2035
*this image is indicative*
Respiratory inhalers are medical devices that are employed to deliver medication directly to the lungs of patients suffering from respiratory disorders. There is a growing trend towards the adoption of digitally operated and smart inhaler technologies in the market. Smart inhalers are known to facilitate effective disease management by monitoring and providing feedback on the patient's usage patterns. Thus, the Asia Pacific respiratory inhalers market growth is significantly influenced by the technological advancements in inhaler devices.
The market is also impacted by the rising burden of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary arterial hypertension in the Asia Pacific region. Recent data reveals that China accounts for nearly 25% of all COPD cases globally, with around 100 million living with this chronic lung condition . Moreover, it is estimated that with the rising smoking rates and an aging population, the prevalence rate of COPD is likely to increase in the coming 40 years. Consequently, the market demand for respiratory inhalers is poised to witness a surge in the forecast period.
One of the major Asia Pacific respiratory inhalers market trends is the increased investment in the respiratory inhaler segment by key market players with the aim to improve access to innovative drugs and accommodate the growing healthcare demands. In August 2023, AstraZeneca announced its plan to invest an additional amount of USD 250 million in its asthma inhaler plant in China’s Qingdao, with the total investment in the factory reported to be USD 700 million. By collaborating with the Qingdao municipal government, the firm intends to manufacture its Budesonide, Glycopyrronium Bromide, and Formoterol Fumarate inhalers for chronic obstructive pulmonary diseases such as asthma. Such substantial investments to address the medical needs of the rising patient pool are expected to elevate the market value.
The increased initiatives and campaigns to raise awareness about respiratory diseases and their management are poised to positively influence the Asia Pacific respiratory inhalers market share. For instance, in May 2023, an Indian multinational pharmaceutical company Alkem Laboratories Limited announced its 'Reliever Free India' initiative to raise awareness about asthma and the hazards of over-usage of reliever medication. The campaign promotes the use of SMART therapy which requires only one inhaler for daily and reliever asthma treatment. The rise of such initiatives coupled with the increasing healthcare expenditure in the region is expected to bolster market growth.
The report offers a detailed analysis of the market based on the following segments:
Breakup by Product Type
Breakup by Technology
Breakup by Indication
Breakup by Distribution Channel
Breakup by End User
Breakup by Region
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Europe Respiratory Inhalers Market
North America Respiratory Inhalers Market
Upto 15% Off
USD
$2699 $2429
$4299 $3869
$5799 $4949
$6999 $5949
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The Asia Pacific respiratory inhalers market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 5.40% during the forecast period of 2026-2035 and is likely to reach a market value of USD 59.75 Billion by 2035.
The rising demand for digitally operated and smart inhaler technologies is fuelling the demand for the market.
One of the significant trends in the market is the increased investment in the respiratory inhaler segment by the key market players. In August 2023 , AstraZeneca invested an additional amount of USD 250 million in its asthma inhaler plant in China’s Qingdao, with the total investment in the factory reported to be USD 700 million.
Based on the product type, the market is segmented into dry powdered inhalers (multi-dose dry powder inhalers, single dose dry powder inhalers), metered dose inhalers (pressured metered dose inhalers, connected metered dose inhalers), and nebulizers (compressed air nebulizers, mesh air nebulizers, ultrasonic air nebulizers), among others.
By technology, the market is divided into manually operated inhalers and digitally operated inhalers.
By indication, the market includes asthma, COPD, and pulmonary arterial hypertension, among other respiratory diseases.
By end use, the market is segmented into hospitals & clinics, homecare settings, and respiratory care centers.
Major distribution channels of the market include hospital pharmacies, retail pharmacies and online pharmacies.
The market segmentation by countries includes China, Japan, India, ASEAN, and Australia, among others.
The key players in the market are AstraZeneca Plc, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Cipla Ltd, GSK Plc, Koninklijke Philips NV, OMRON Corp, PARI Respiratory Equipment, Inc., OPKO Health, Inc., and Teva Pharmaceutical Industries Ltd.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Technology |
|
| Breakup by Indication |
|
| Breakup by Distribution Channel |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share